After an initial growth phase of about 5 weeks, Nude-Foxn1nu/nu hosts were further treated with TM to assure efficient recombination of target genes, upon which tumor growth of the Wnt GOF group was decreased, while tumors of Ctrl and Ezh2 GOF groups remained unaffected (Fig. 6B). The gene discussed is CTRL; the disease is neoplasm.